Evidence map›Paper›PMID 29226097›Full record

ArticleJournal of clinical and translational hepatology2017

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng and 11 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 2 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 2 syntheses or guidelines pooled it, 275 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Response to Yang et al.Clinical and translational gastroenterology · 2025
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 1 country.

Jinlin HouDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guiqiang WangDepartment of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
Fusheng WangThe Institute of Translational Hepatology, 302 Hospital of PLA, Peking University, Beijing, China.
Jun ChengCenter of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hong RenInstitute for Viral Hepatitis, the Key Laboratory of Molecular Biology for Infectious Diseases, the second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hui ZhuangDepartment of Microbiology of Peking University Health Science Center, Beijing, China.
Jian SunDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lanjuan LiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Jie LiDepartment of Microbiology of Peking University Health Science Center, Beijing, China.
Qinghua MengSerious Illness Medicine Inpatient Area, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Jingmin ZhaoDepartment of Pathology, 302 Hospital of PLA, Peking University, Beijing, China.
Zhongping DuanArtificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Jidong JiaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hong TangCenter of Infectious Diseases, West China Hospital of Sichuan University, Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Jifang ShengState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Jie PengDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fengmin LuDepartment of Microbiology of Peking University Health Science Center, Beijing, China.
Qing XieDepartment of Infectious Diseases, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.
Lai WeiHepatology Institute, Peking University People's Hospital, Beijing, China.
Chinese Society of Hepatology, Chinese Medical Association
Chinese Society of Infectious Diseases, Chinese Medical Association
Nanfang Hospital · CNBeijing Ditan Hospital · CNBeijing Friendship Hospital · CNBeijing YouAn Hospital · CNPeking University First Hospital · CNPeking University People's Hospital · CNSouthern Medical University · CNState Key Laboratory of Diagnosis and Treatment of Infectious DiseasesZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChronicGuidelineHepatitis BPreventionTreatment

Identifiers

PMID29226097
PMCPMC5719188
OpenAlexW2768065696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.